8-KRegulation FD

Elevance Health, Inc. 8-K Report, Regulation FD Disclosure (Apr 2, 2007)

Filed April 2, 2007For Securities:ELV

Summary

Elevance Health, Inc. (then WellPoint, Inc.) filed this Form 8-K on April 2, 2007, to disclose information regarding upcoming meetings with securities analysts and investors. The primary purpose of these meetings, scheduled between April 3 and April 10, 2007, was to reaffirm the company's ability to meet previously issued earnings expectations. These expectations were initially communicated through a press release and conference call on January 24, 2007. Investors and analysts were informed that WellPoint's management anticipated confirming its performance against these targets during the upcoming engagements. This filing serves as a standard Regulation FD disclosure, ensuring that material information is broadly disseminated to the public.

Key Highlights

  • 1Company (then WellPoint, Inc.) scheduled meetings with securities analysts and investors from April 3 to April 10, 2007.
  • 2The purpose of these meetings was to confirm the company's ability to meet prior earnings expectations.
  • 3Earnings expectations were previously established on January 24, 2007, via a press release and conference call.
  • 4This filing is a Regulation FD disclosure to ensure broad dissemination of information.
  • 5Information furnished in this report is not considered 'filed' for Section 18 purposes and will not be incorporated into future filings.
  • 6Angela F. Braly, Executive Vice President, General Counsel and Chief Public Affairs Officer, signed the report.

Frequently Asked Questions

The main purpose of this 8-K filing is to inform the public that Elevance Health (then WellPoint, Inc.) officers would be meeting with analysts and investors to reaffirm the company's ability to meet previously stated earnings expectations.

The earnings expectations were originally communicated on January 24, 2007, through a press release and a conference call.

Regulation FD (Fair Disclosure) is an SEC rule that requires public companies to disclose material non-public information to the public in a broad and non-exclusionary manner. This filing ensures that the confirmation of earnings expectations is made available to all investors, not just those attending the private meetings.

No, the filing explicitly states that the information furnished in this report shall not be deemed to be 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor will it be incorporated by reference into any future filings.